BamSEC and AlphaSense Join Forces
Learn More

Cue Biopharma Inc. – Indentures

NASDAQ: CUE    
Share price (7/2/26): $28.26    
Market cap (7/2/26): $119 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 15 pages Form of Common Stock Purchase Warrant Cue Biopharma, Inc
12/34/56
EX-4.2
from 8-K 11 pages Cue Biopharma, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 12 pages Cue Biopharma, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 61 pages Cue Biopharma, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 59 pages Cue Biopharma, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.2
from 10-K 5 pages Description of Common Stock of Cue Biopharma, Inc. Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 18 pages Form of Common Stock Purchase Warrant Cue Biopharma, Inc
12/34/56
EX-4.1
from 8-K 14 pages Cue Biopharma, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 18 pages Form of Common Stock Purchase Warrant Cue Biopharma, Inc
12/34/56
EX-4.1
from 8-K 14 pages Cue Biopharma, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 10-K 5 pages Description of Common Stock of Cue Biopharma, Inc. Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 18 pages Form of Common Stock Purchase Warrant Cue Biopharma, Inc
12/34/56
EX-4.1
from 8-K 14 pages Cue Biopharma, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 10-K 5 pages Description of Common Stock of Cue Biopharma, Inc. Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 61 pages Cue Biopharma, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 59 pages Cue Biopharma, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56